Specifications
| Publisher | Taylor And Francis Ltd |
| ISBN 13 | 9781439841655 |
| ISBN 10 | 1439841659 |
| Book Description | Bridging the gap between research and clinical application, Biosensors and Molecular Technologies for Cancer Diagnostics explores the use of biosensors as effective alternatives to the current standard methods in cancer diagnosis and detection. It describes the major aspects involved in detecting and diagnosing cancer as well as the basic elements of biosensors and their applications in detection and diagnostics. The book addresses cancer molecular diagnostics, including genomic and proteomic approaches, from the perspective of biosensors and biodetection. It explains how to measure and understand molecular markers using biosensors and discusses the medical advantages of rapid and accurate cancer diagnostics. It also describes optical, electrochemical, and optomechanical biosensor technologies, with a focus on cancer analysis and the clinical utility of these technologies for cancer detection, diagnostics, prognostics, and treatment. Making biosensor technology more accessible to molecular biologists, oncologists, pathologists, and engineers, this volume advances the integration of this technology into mainstream clinical practice. Through its in-depth coverage of a range of biosensors, the book shows how they can play instrumental roles in the early molecular diagnosis of cancer. |
| Editorial Review | "... a good mixture of some of the cutting-edge research ideas and some of the more established workhorse techniques ... a useful book for researchers in the field for the next few years and I recommend it for its style and clarity." -Peter J. Dobson, Contemporary Physics, Vol. 54, 2013 |
| About the Author | Keith E. Herold is an associate professor in the Fischell Department of Bioengineering at the University of Maryland. A fellow of the ASME, Dr. Herold has over 10 years of experience in the analysis and testing of biosensor systems. His current research interests include bioMEMS, microfluidic systems for bioanalytical assays, and heat and mass transfer in bioengineering. Avraham Rasooly is the chief of the Disparities Research Branch at the National Cancer Institute and a member of the Division of Biology in the Center for Devices and Radiological Health at the U.S. Food and Drug Administration. |
| Language | English |
| Author | Herold, Keith E. |
| Editor | Keith E. Herold, Avraham Rasooly |
| Publication Date | 29 May 2012 |
| Number of Pages | 844 |
Biosensors And Molecular Technologies For Cancer Diagnostics hardcover english - 29 May 2012
Added to cart
Cart Total SAR 0.00
